U.S. federal trademark · Serial No. 77983427 · Reg. No. 4254342
Pharmaceutical drug and therapeutics research and development services, namely, providing screening platforms and technologies for characterization and testing of compounds for their impact on the human body's circadian rhythms and circadian activity and for development of pharmaceutical drugs and therapeutics for treatment of circadian rhythm metabolism, circadian rhythm disturbances and dysfunction, and associated metabolic disorders
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.